About this Research Topic
It has become increasingly clear that diseases that progress into dementia have their origins in mid-life, so the identification of these prior to symptomatic stages may lead to the development of effective preventative and disease-modifying interventions. Consistently, researchers are striving to find sets of early biomarkers, which can recognize and track disease progress, that are accessible and cost-effective. If either primary and secondary prevention (or even delay of dementia onset) could be achieved via a combination of lifestyle modification and drug therapies, that would surely be one of the biggest health successes of this century.
We aim to summarize the current status of early biomarker, risk, and preventative factor identification via a variety of studies (genetic, imaging, and cohort studies etc.), as well as how these could be implemented in clinical settings internationally.
Areas of interest include, but are not limited to the following:
· Review articles on how various risk and preventative factors (whether biological, genetic, lifestyle, comorbidities etc.), affect preclinical/prodromal disease, including mechanistically.
· Review/Perspectives on the direction of dementia prevention, including how collaborative research efforts are expanding.
· New research around biomarkers and risk factors in cohort studies.
· Analytical methods in relation to progression of preclinical/prodromal disease.
· Clinical service research around brain health and adaptations of services to earlier disease models in differing clinical setting.
Keywords: Neurodegeneration, dementia, prevention, environmental factors, cognition, brain health
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.